Moody’s raised the outlook due to earnings growth expectations resulting from LifePoint’s recent acquisitions, strategic partnerships and physician recruitment efforts, according to the report.
LifePoint currently holds a Ba3 rating from Moody’s, according to the report.
Related Articles on LifePoint Hospitals:
LifePoint Hospitals Authorizes $250M Stock Repurchase Program
Duke LifePoint JV to Acquire Person Memorial Hospital
LifePoint Hospitals to Pay $1M Settlement for Alleged Medicare Overbilling
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
